Skip to content
GLP-1 Decoder

Saxenda Vial: What It Is, Price and How It Differs from the Pen

Saxenda vial: which forms exist, which are FDA approved, and how they differ.

Active ingredient
liraglutide
Manufacturer
Novo Nordisk
How it is taken
Daily injection
FDA-approved for
Weight loss
Saxenda vial: GLP-1 medicines as a pen, a pill and a vial

Saxenda: key facts

How long it remains in your body
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

With a half-life of about 13 hours, the amount falls by half in 13 h. Following five half-lives (2.7 d), about 3% remains.

Weight loss in its main trial
Saxenda (SCALE Obesity and Prediabetes)7.4%Placebo3%

In the SCALE Obesity and Prediabetes, 56-week study, the reported figure was 7.4% of body weight, compared with 3% for placebo.

Sources: FDA label (DailyMed).